Keli Song

927 total citations
19 papers, 475 citations indexed

About

Keli Song is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Keli Song has authored 19 papers receiving a total of 475 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 11 papers in Immunology and 7 papers in Oncology. Recurrent topics in Keli Song's work include Macrophage Migration Inhibitory Factor (6 papers), Cell death mechanisms and regulation (5 papers) and Ubiquitin and proteasome pathways (5 papers). Keli Song is often cited by papers focused on Macrophage Migration Inhibitory Factor (6 papers), Cell death mechanisms and regulation (5 papers) and Ubiquitin and proteasome pathways (5 papers). Keli Song collaborates with scholars based in United States, Japan and Australia. Keli Song's co-authors include Roya Khosravi‐Far, Thomas G. Brock, Marc Peters‐Golden, Zainab Jagani, Alexandra Grassian, Octavian Bucur, Mark Duquette, Jack Lawler, Rabindranath Chakrabarti and Yigang Chang and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Keli Song

19 papers receiving 470 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Keli Song United States 10 336 120 105 58 49 19 475
Pushpankur Ghoshal United States 15 289 0.9× 81 0.7× 84 0.8× 88 1.5× 79 1.6× 23 520
Kerstin Brinkmann Germany 14 411 1.2× 143 1.2× 113 1.1× 95 1.6× 51 1.0× 21 551
Julie C. Watt United States 9 382 1.1× 136 1.1× 110 1.0× 62 1.1× 34 0.7× 10 520
Amrik Singh United States 10 382 1.1× 88 0.7× 56 0.5× 65 1.1× 54 1.1× 13 498
Huihong You United States 10 274 0.8× 70 0.6× 56 0.5× 56 1.0× 67 1.4× 13 522
Lilian Stärck Germany 8 337 1.0× 203 1.7× 177 1.7× 50 0.9× 33 0.7× 12 540
Meike Dahlhaus Germany 9 389 1.2× 132 1.1× 288 2.7× 51 0.9× 39 0.8× 17 612
Xiaotang Hu United States 13 252 0.8× 137 1.1× 90 0.9× 91 1.6× 33 0.7× 21 418
Julie A. Wickenden United Kingdom 6 341 1.0× 173 1.4× 93 0.9× 71 1.2× 41 0.8× 7 529
Erin L. Filbert United States 7 284 0.8× 84 0.7× 172 1.6× 32 0.6× 84 1.7× 19 526

Countries citing papers authored by Keli Song

Since Specialization
Citations

This map shows the geographic impact of Keli Song's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keli Song with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keli Song more than expected).

Fields of papers citing papers by Keli Song

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keli Song. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keli Song. The network helps show where Keli Song may publish in the future.

Co-authorship network of co-authors of Keli Song

This figure shows the co-authorship network connecting the top 25 collaborators of Keli Song. A scholar is included among the top collaborators of Keli Song based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keli Song. Keli Song is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Nakamura, Akito, Stephen Grossman, Keli Song, et al.. (2022). The SUMOylation inhibitor subasumstat potentiates rituximab activity by IFN1-dependent macrophage and NK cell stimulation. Blood. 139(18). 2770–2781. 43 indexed citations
2.
Nakamura, Akito, Keli Song, Stephen Grossman, et al.. (2021). The Sumoylation Inhibitor TAK-981 in Combination with the CD19-Targeting Antibody Tafasitamab Shows Enhanced Anti-Tumor Activity in Preclinical B-Cell Lymphoma Models. Blood. 138(Supplement 1). 2268–2268. 1 indexed citations
3.
Nakamura, Akito, Keli Song, Stephen Grossman, et al.. (2020). 552 SUMOylation inhibitor TAK-981 activates NK cells and macrophages via Type I interferon signaling and shows synergistic activity in combination with rituximab and daratumumab in preclinical models. SHILAP Revista de lepidopterología. A334.2–A335. 1 indexed citations
4.
Khattar, Mithun, Keli Song, Stephen Grossman, et al.. (2019). Abstract 3252: TAK-981: A first in class SUMO inhibitor in Phase 1 trials that promotes dendritic cell activation, antigen-presentation, and T cell priming. Immunology. 3252–3252. 2 indexed citations
5.
Berger, Allison, Sharon Friedlander, Omid Ghasemi, et al.. (2019). Abstract 3079: Pharmacodynamic evaluation of the novel SUMOylation inhibitor TAK-981 in a mouse tumor model. Cancer Research. 79(13_Supplement). 3079–3079. 4 indexed citations
6.
Berger, Allison, Sharon Friedlander, Omid Ghasemi, et al.. (2019). Abstract 3079: Pharmacodynamic evaluation of the novel SUMOylation inhibitor TAK-981 in a mouse tumor model. 3079–3079. 1 indexed citations
7.
Khattar, Mithun, Keli Song, Stephen Grossman, et al.. (2019). Abstract 3252: TAK-981: A first in class SUMO inhibitor in Phase 1 trials that promotes dendritic cell activation, antigen-presentation, and T cell priming. Cancer Research. 79(13_Supplement). 3252–3252. 10 indexed citations
8.
9.
10.
Koenig, Erik, Pooja Shah, Michael Fitzgerald, et al.. (2013). Abstract A169: Assessment of genotype-correlated sensitivity to the investigational PI3Kα selective inhibitor MLN1117 in preclinical models.. Molecular Cancer Therapeutics. 12(11_Supplement). A169–A169. 2 indexed citations
11.
Kazerounian, Shideh, Mark Duquette, Keli Song, et al.. (2011). Priming of the vascular endothelial growth factor signaling pathway by thrombospondin-1, CD36, and spleen tyrosine kinase. Blood. 117(17). 4658–4666. 52 indexed citations
12.
Jagani, Zainab, Keli Song, Jeffery L. Kutok, et al.. (2009). Proteasome Inhibition Causes Regression of Leukemia and Abrogates BCR-ABL–Induced Evasion of Apoptosis in Part through Regulation of Forkhead Tumor Suppressors. Cancer Research. 69(16). 6546–6555. 40 indexed citations
13.
Ren, Bin, Keli Song, Sareh Parangi, et al.. (2009). A Double Hit to Kill Tumor and Endothelial Cells by TRAIL and Antiangiogenic 3TSR. Cancer Research. 69(9). 3856–3865. 44 indexed citations
14.
Song, Keli, et al.. (2008). Chapter 19 Analysis of Tnf‐Related Apoptosis‐Inducing Ligand In Vivo Through Bone Marrow Transduction and Transplantation. Methods in enzymology on CD-ROM/Methods in enzymology. 446. 315–331. 3 indexed citations
15.
Song, Keli, et al.. (2007). Apoptotic Pathways in Tumor Progression and Therapy. Advances in experimental medicine and biology. 615. 47–79. 80 indexed citations
16.
17.
Kurakin, Alexei, Karon Abe, Mehrdad Mohseni, et al.. (2004). Fas-associated Protein with Death Domain (FADD)-independent Recruitment of c-FLIPL to Death Receptor 5. Journal of Biological Chemistry. 279(53). 55594–55601. 27 indexed citations
18.
Chakrabarti, Rabindranath, Yigang Chang, Keli Song, & Gérald J. Prud’homme. (2003). Plasmids encoding membrane-bound IL-4 or IL-12 strongly costimulate DNA vaccination against carcinoembryonic antigen (CEA). Vaccine. 22(9-10). 1199–1205. 30 indexed citations
19.
Peters‐Golden, Marc, et al.. (1996). Translocation of cytosolic phospholipase A2 to the nuclear envelope elicits topographically localized phospholipid hydrolysis. Biochemical Journal. 318(3). 797–803. 104 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pushpankur Ghoshal Breakdown of academic impact, for papers by Kerstin Brinkmann Breakdown of academic impact, for papers by Julie C. Watt Breakdown of academic impact, for papers by Amrik Singh Breakdown of academic impact, for papers by Huihong You Breakdown of academic impact, for papers by Lilian Stärck Breakdown of academic impact, for papers by Meike Dahlhaus Breakdown of academic impact, for papers by Xiaotang Hu Breakdown of academic impact, for papers by Julie A. Wickenden Breakdown of academic impact, for papers by Erin L. Filbert
Rankless by CCL
2026